Inyx USA

Inyx USA was a specialty pharmaceutical company and contract development and manufacturing organization (CDMO) focused on respiratory and inhalation drug delivery systems. The company specialized in the production of metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nasal sprays for conditions such as asthma and COPD. Operating primarily out of a large manufacturing facility in Manati, Puerto Rico, Inyx provided development and manufacturing services to global pharmaceutical partners while maintaining its own portfolio of generic products. The company was a subsidiary of Inyx, Inc. and was publicly traded before entering into bankruptcy and receivership in 2007 following severe financial instability. Its assets were eventually liquidated after a series of legal disputes involving its primary lender and executive leadership.